Cargando…
P102: Comparison of Novel Salvage Regimens and Traditional salvage Chemotherapy in Relapsed and Refractory Classic Hodgkin Lymphoma
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621536/ http://dx.doi.org/10.1097/01.HS9.0000890976.21005.88 |
| _version_ | 1784821579750834176 |
|---|---|
| author | Shah, Harsh Vardell, Victoria Zacholski, Erin Fegley, Amanda Fedak, Kalub Sundaram, Suchitra Rajeeve, Sridevi Goyal, Gaurav Hatic, Haris Torka, Pallawi Ba Aqeel, Sheeba Borogovac, Azra Macdougall, Kira Kothari, Shalin Kress, Anna Modi, Dipenkumar Travers, Elizabeth Chilakamarri, Nitin Brem, Elizabeth Stephens, Deborah M. Hu, Boyu Fitzgerlad, Lindsey Wagner, Charlotte Ermann, Daniel |
| author_facet | Shah, Harsh Vardell, Victoria Zacholski, Erin Fegley, Amanda Fedak, Kalub Sundaram, Suchitra Rajeeve, Sridevi Goyal, Gaurav Hatic, Haris Torka, Pallawi Ba Aqeel, Sheeba Borogovac, Azra Macdougall, Kira Kothari, Shalin Kress, Anna Modi, Dipenkumar Travers, Elizabeth Chilakamarri, Nitin Brem, Elizabeth Stephens, Deborah M. Hu, Boyu Fitzgerlad, Lindsey Wagner, Charlotte Ermann, Daniel |
| author_sort | Shah, Harsh |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9621536 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96215362022-11-01 P102: Comparison of Novel Salvage Regimens and Traditional salvage Chemotherapy in Relapsed and Refractory Classic Hodgkin Lymphoma Shah, Harsh Vardell, Victoria Zacholski, Erin Fegley, Amanda Fedak, Kalub Sundaram, Suchitra Rajeeve, Sridevi Goyal, Gaurav Hatic, Haris Torka, Pallawi Ba Aqeel, Sheeba Borogovac, Azra Macdougall, Kira Kothari, Shalin Kress, Anna Modi, Dipenkumar Travers, Elizabeth Chilakamarri, Nitin Brem, Elizabeth Stephens, Deborah M. Hu, Boyu Fitzgerlad, Lindsey Wagner, Charlotte Ermann, Daniel Hemasphere Relapsed/Refractory Lippincott Williams & Wilkins 2022-10-03 /pmc/articles/PMC9621536/ http://dx.doi.org/10.1097/01.HS9.0000890976.21005.88 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Relapsed/Refractory Shah, Harsh Vardell, Victoria Zacholski, Erin Fegley, Amanda Fedak, Kalub Sundaram, Suchitra Rajeeve, Sridevi Goyal, Gaurav Hatic, Haris Torka, Pallawi Ba Aqeel, Sheeba Borogovac, Azra Macdougall, Kira Kothari, Shalin Kress, Anna Modi, Dipenkumar Travers, Elizabeth Chilakamarri, Nitin Brem, Elizabeth Stephens, Deborah M. Hu, Boyu Fitzgerlad, Lindsey Wagner, Charlotte Ermann, Daniel P102: Comparison of Novel Salvage Regimens and Traditional salvage Chemotherapy in Relapsed and Refractory Classic Hodgkin Lymphoma |
| title | P102: Comparison of Novel Salvage Regimens and Traditional salvage Chemotherapy in Relapsed and Refractory Classic Hodgkin Lymphoma |
| title_full | P102: Comparison of Novel Salvage Regimens and Traditional salvage Chemotherapy in Relapsed and Refractory Classic Hodgkin Lymphoma |
| title_fullStr | P102: Comparison of Novel Salvage Regimens and Traditional salvage Chemotherapy in Relapsed and Refractory Classic Hodgkin Lymphoma |
| title_full_unstemmed | P102: Comparison of Novel Salvage Regimens and Traditional salvage Chemotherapy in Relapsed and Refractory Classic Hodgkin Lymphoma |
| title_short | P102: Comparison of Novel Salvage Regimens and Traditional salvage Chemotherapy in Relapsed and Refractory Classic Hodgkin Lymphoma |
| title_sort | p102: comparison of novel salvage regimens and traditional salvage chemotherapy in relapsed and refractory classic hodgkin lymphoma |
| topic | Relapsed/Refractory |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621536/ http://dx.doi.org/10.1097/01.HS9.0000890976.21005.88 |
| work_keys_str_mv | AT shahharsh p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT vardellvictoria p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT zacholskierin p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT fegleyamanda p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT fedakkalub p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT sundaramsuchitra p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT rajeevesridevi p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT goyalgaurav p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT haticharis p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT torkapallawi p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT baaqeelsheeba p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT borogovacazra p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT macdougallkira p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT kotharishalin p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT kressanna p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT modidipenkumar p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT traverselizabeth p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT chilakamarrinitin p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT bremelizabeth p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT stephensdeborahm p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT huboyu p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT fitzgerladlindsey p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT wagnercharlotte p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma AT ermanndaniel p102comparisonofnovelsalvageregimensandtraditionalsalvagechemotherapyinrelapsedandrefractoryclassichodgkinlymphoma |